Pulmonary Sarcoidosis following Etanercept Treatment

Pulmonary Sarcoidosis following Etanercept Treatment

Tumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like gran...

Full description

Bibliographic Details
Main Authors: Kuljeet Bhamra, Richard Stevens
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2012/724013
id doaj-9e06650dc6564f57b6b4e3b71d7b27ee
record_format Article
spelling doaj-9e06650dc6564f57b6b4e3b71d7b27ee2020-11-24T21:24:41ZengHindawi LimitedCase Reports in Rheumatology2090-68892090-68972012-01-01201210.1155/2012/724013724013Pulmonary Sarcoidosis following Etanercept TreatmentKuljeet Bhamra0Richard Stevens1Department of Rheumatology, Wycombe General Hospital, Queen Alexander Road, Wycome, Buckinghamshire HP11 2TT, UKDepartment of Rheumatology, Wycombe General Hospital, Queen Alexander Road, Wycome, Buckinghamshire HP11 2TT, UKTumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like granulomatous disease developing after the initiation of anti-TNF-α therapy, with disease reversal after discontinuation.http://dx.doi.org/10.1155/2012/724013
collection DOAJ
language English
format Article
sources DOAJ
author Kuljeet Bhamra
Richard Stevens
spellingShingle Kuljeet Bhamra
Richard Stevens
Pulmonary Sarcoidosis following Etanercept Treatment
Case Reports in Rheumatology
author_facet Kuljeet Bhamra
Richard Stevens
author_sort Kuljeet Bhamra
title Pulmonary Sarcoidosis following Etanercept Treatment
title_short Pulmonary Sarcoidosis following Etanercept Treatment
title_full Pulmonary Sarcoidosis following Etanercept Treatment
title_fullStr Pulmonary Sarcoidosis following Etanercept Treatment
title_full_unstemmed Pulmonary Sarcoidosis following Etanercept Treatment
title_sort pulmonary sarcoidosis following etanercept treatment
publisher Hindawi Limited
series Case Reports in Rheumatology
issn 2090-6889
2090-6897
publishDate 2012-01-01
description Tumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like granulomatous disease developing after the initiation of anti-TNF-α therapy, with disease reversal after discontinuation.
url http://dx.doi.org/10.1155/2012/724013
work_keys_str_mv AT kuljeetbhamra pulmonarysarcoidosisfollowingetanercepttreatment
AT richardstevens pulmonarysarcoidosisfollowingetanercepttreatment
_version_ 1725986708732772352

Similar Items